A brief history of psychiatry: Millennia past and present. Part IV

Annals of Clinical Psychiatry

Volumn 11, Issue 4, 1999, Pages 175-185

  King, Lucy Jane ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Diagnosis; Historical; Institutional; Neurobiology; Psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONIDINE; HYPNOTIC SEDATIVE AGENT; LITHIUM; MEPROBAMATE; NEUROLEPTIC AGENT; RESERPINE;

BEHAVIOR; BRAIN FUNCTION; COMPUTER ASSISTED TOMOGRAPHY; DRUG COST; ELECTROENCEPHALOGRAM; ENVIRONMENTAL FACTOR; HEREDITY; HISTORY OF MEDICINE; HUMAN; MENTAL DISEASE; MOLECULAR BIOLOGY; NEUROBIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHILOSOPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHIATRY; PSYCHOLOGY; PSYCHOTHERAPY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIOLOGY;

EID: 0032732593     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.3109/10401239909147069     Document Type: Review

References (38)

1. Kalant H: Research on tolerance; what can we learn from history. Alcohol Clin Exp Res 1998; 22:66-76
2. Griesinger W: Mental Pathology and Therapeutics [1867]. New York: Hafner; 1965
3. Weiss JM, Kitts CD: Animal models of depression. In: Schatzberg AF, Nemeroff CP, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1995, Chapter 5
4. Hyman SE, Nestler EJ: The Molecular Foundations of Psychiatry. Washington, DC: American Psychiatric Press, 1993
5. Zuckerman M: Psychobiology of Personality. Cambridge: Cambridge University Press; 1991
6. Kendler KS: Genetic epidemiology in psychiatry: taking both genes and environment seriously. Arch Gen Psychiatry 1995; 52:895-899
7. Jones P, Cannon M: The new epidemiology of schizophrenia. Psychiatr Clin North Am 1998; 21:1-25
8. Cohen J: The genomics gamble. Science 1997; 275:767-772
9. Lee A: The Helicobacter pylori genome - new insights into pathogenesis and therapeutics. New Eng J Med 1998; 338:832-833
10. Cloninger CR, Svrakic DM, Przybeck TR: A psychobiological-model of temperament and character. Arch Gen Psychiatry 1997; 54:975-990
11. Cloninger CR: Medical Update 1998, Washington University, St. Louis, MO, May 7, 1998
12. Tsuang MT, Tonen M, Zahner GEP: Textbook in Psychiatric Epidemiology. New York: Wiley-Liss; 1995
13. Loudon I: Western Medicine, an Illustrated History. Oxford: Oxford University Press; 1997
14. Dohrenwend BP: The problem of validity in field studies of psychological disorders revisited. In: Tsuang MT, Tohen M, Zahner GEP, eds. Textbook in Psychiatric Epidemiology. New York: Wiley-Liss; 1995, Chapter 1
15. Robins LN, Regier DA, eds: Psychiatric Disorders in America, the Epidemiologic Catchment Area Study. New York: Free Press; 1991
16. Kessler RC: Epidemiology of psychiatric comorbidity. In: Tsuang MT, Tohen M, Zahner GEP: Textbook in Psychiatric Epidemiology. New York: Wiley-Liss; 1995, Chapter 7.
17. Finger S: Origins of Neuroscience, a History of Explorations into Brain Function. Oxford: Oxford University Press; 1994
18. Cooper JR, Bloom FE, Roth RH: The Biochemical Basis of Neuropharmacology, 7th ed. Oxford: Oxford University Press; 1996
19. Woodward DJ, Janak PH, Chang JY: Ethanol action on neural networks studied with multineuron recording in freely moving animals. Alcohol Clin Exp Res 1998; 22:10-22
20. Andreasen NC, Black DW: Introductory Textbook of Psychiatry, 2nd ed. Washington, DC: American Psychiatric Press; 1994, pp. 99-119
21. Sharma A, Malhotra S, Raghunathan M, Malhotra A: A study of event-related potential - P3 characteristics in children of alcoholics. Addiction Biol 1997; 2:431-438
22. Gilman S: Imaging the Brain. N Engl J Med 1998; 338:812-820, 889-896
23. Shorter E: A History of Psychiatry, from the Era of the Asylum to the Age of Prozac, New York: Wiley; 1997
24. Krishnan, KRR: Monoamine oxidase inhibitors. In: Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology. Washington DC: American Psychiatric Press; 1995, Chapter 9
25. Potter WZ, Manji HK, Rudorfer MV: Tricyclics and tetracyclics. In: Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology. Washington DC: American Psychiatric Press; 1995, Chapter 7
26. Tollefson GD: Selective serotonin reuptake inhibitors. In: Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology, Washington DC: American Psychiatric Press; 1995, Chapter 8
27. Golden RN, Bebchuk JM, Leatherman ME: Trazodone and other antidepressants. In Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology. Washington DC: American Psychiatric Press; 1995, Chapter 10
28. Stahl SM: Basic psychopharmacology of antidepressants, Part 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 1998; 59 (suppl 4):5-14
29. Marder SR, Van Putten T: Antipsychotic medications. In: Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology. Washington DC: American Psychiatric Press; 1995, Chapter 13
30. Owens MJ, Risch SC: Atypical antipsychotics. In: Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology. Washington DC: American Psychiatric Press; 1995, Chapter 14
31. Lenox RH, Manji HK: Lithium. In: Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology. Washington DC: American Psychiatric Press; 1995, Chapter 16.
32. McElroy SL, Keck PE: Antiepileptic drugs. In: Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology. Washington DC: American Psychiatric Press; 1995, Chapter 17
33. Cole JO, Yonkers KA: Nonbenzodiazepine anxiolytics. In: Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology. Washington DC: American Psychiatric Press, 1995, Chapter 12
34. Ballenger JC: Benzodiazepines. In: Schatzberg AF, Nemeroff CP: Textbook of Psychopharmacology. Washington DC, American Psychiatric Press; 1995, Chapter 11
35. Zito JM: Pharmacoeconomics of the new antipsychotics for the treatment of schizophrenia. Psychiatr Clin North Am 1998; 21:181-202
36. Kandel ER: A new intellectual framework for psychiatry. Am J Psychiatry 1998; 155:457-469
37. Lehman AF: Public health policy, community services, and outcomes for patients with schizophrenia. Psychiatr Clin North Am 1998; 21:221-232
38. Frese FJ III: Advocacy, recovery, and the challenges of consumerism for schizophrenia. Psychiatr Clin North Am 1998; 21:233-249